Which laboratory tests should be ordered to evaluate a patient with extreme fatigue suspected of an infectious etiology?

Laboratory Testing for Extreme Fatigue with Suspected Infectious Etiology

For a patient with extreme fatigue suspected to be infectious in origin, order a focused initial panel including: complete blood count with differential, comprehensive metabolic panel (including liver function tests), erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP), HIV serology, EBV-specific antibodies (VCA IgM/IgG and EBNA), and CMV IgM/IgG. Additional testing should be guided by specific clinical features, exposures, and initial results rather than ordering an exhaustive battery upfront.

Initial Laboratory Approach

The evidence shows that broad laboratory testing in chronic fatigue has a low diagnostic yield for serious disease 1, 2. However, when infectious etiology is specifically suspected, a targeted approach is warranted.

Core Initial Tests

Basic hematologic and metabolic assessment:

• Complete blood count with differential - Look for lymphocytosis, atypical lymphocytosis, monocytosis, or lymphopenia 3, 4. Lymphopenia has been noted in severe viral infections, while lymphocytosis with atypical lymphocytes suggests EBV or CMV.
• Comprehensive metabolic panel (electrolytes, renal function, liver enzymes) - Hepatocellular enzyme elevation may indicate viral hepatitis or EBV/CMV infection 3, 4
• ESR or CRP - ESR is often elevated with infectious processes and provides an inexpensive measure of systemic inflammation 5. CRP may be useful when bacterial superinfection is suspected 3

Infectious disease screening:

• HIV serology (consider RNA if acute infection suspected) 6, 7
• EBV-specific serology - VCA IgM/IgG and EBNA antibodies 8. Note that heterophile antibody (Monospot) tests have up to 10% false negatives, especially in younger patients 8
• CMV IgM and IgG 8, 4

Critical Caveat About EBV Testing

Research shows that elevated EBV early antigen antibodies do not correlate with chronic fatigue outcomes 9. The presence of EBV DNA in pharyngeal specimens also does not reliably correlate with symptoms 10. Therefore, avoid ordering EBV early antigen antibodies or EBV DNA quantification for routine fatigue evaluation—these tests are not clinically useful in this context despite historical overuse.

Exposure and Symptom-Directed Testing

If specific exposures or symptoms are present, add:

Respiratory symptoms present:

• Mycoplasma pneumoniae serology and throat PCR 6
• Respiratory virus testing (influenza, RSV) 8
• Chest imaging if pneumonia suspected 3

Tick exposure or summer/fall presentation:

• Lyme disease two-tier testing (EIA followed by Western blot if positive) 8
• Peripheral blood smear for Babesia, Ehrlichia, Anaplasma 8
• Consider tick-borne disease panel based on geographic location

Travel history to endemic areas:

• Malaria smears if appropriate exposure
• Arbovirus testing based on geography 6

Neurologic symptoms (confusion, altered mental status):

• Lumbar puncture with CSF analysis if encephalitis suspected 6, 7

Immunocompromised patients:

• CMV viral load (quantitative PCR) 8
• Toxoplasma serology 6
• Fungal testing (cryptococcal antigen) 7

Monitoring and Follow-up Testing

If initial infectious workup is positive:

• Repeat ESR every 1-4 weeks to monitor treatment response 5
• Repeat specific antibody titers (acute and convalescent sera 10-14 days apart) for definitive diagnosis 6, 7
• Avoid repeating serologic tests more frequently than every 2 weeks 5

If initial workup is negative but symptoms persist:

• Consider that psychological causes predominate in fatigue lasting >1 year 2
• Laboratory abnormalities in chronic fatigue patients often do not indicate the cause of fatigue 2
• Avoid repetitive testing without new clinical indications

What NOT to Order

• Extensive autoimmune panels without specific clinical indicators
• EBV early antigen antibodies - not clinically useful 9
• Routine EBV or CMV viral load testing in immunocompetent patients 8
• Broad "fatigue panels" - these have poor diagnostic yield 1, 2

The key is recognizing that while infectious causes should be investigated when clinically suspected, the majority of chronic fatigue cases will not have identifiable infectious etiologies on laboratory testing 1, 2. Target your testing based on specific clinical features rather than ordering comprehensive panels reflexively.